Mark Mallon

Mark W.
Mallon currently works at George Medicines UK Ltd., as Chief Executive Officer & Director from 2024.
Mr. Mallon also formerly worked at NeoGenomics, Inc., as Chief Executive Officer & Director from 2021 to 2022, Ironwood Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2019 to 2021, NeoGenomics Laboratories, Inc., as Chief Executive Officer & Director, Christiana Care Corp., as Director, AstraZeneca PLC, as Executive Vice President-International, AstraZeneca Pharmaceuticals LP, as Vice President-Marketing & Sales Operations, AstraZeneca SpA, as Vice President-US Sales, AstraZeneca Japan Ltd., as Chief Operating Officer from 2009 to 2011, and Astrazeneca China Ltd., as President in 2011.
Mr. Mallon received his undergraduate degree from the University of Pennsylvania and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.